New rules are in place for the use of glp-1s, particularly for individuals in their 50s. The guidelines may address concerns about safety, side effects, and weight loss associated with these medications. However, the specifics of these rules and their implications are unclear, with various reports focusing on different aspects of glp-1s, including their use, risks, and effects.